midazolam has been researched along with lysergic acid diethylamide in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Abouchedid, R; Archer, JR; Dargan, PI; Dines, A; Ho, JH; Hudson, S; Wood, DM | 1 |
| Auwärter, V; Brandt, SD; Grumann, C; Henkel, K; Hermanns-Clausen, M; Passie, T; Stratford, A | 1 |
| Berg, JA; Brodwall, K; Teigen, IA | 1 |
4 other study(ies) available for midazolam and lysergic acid diethylamide
| Article | Year |
|---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Acute Toxicity Associated with Use of 5F-Derivations of Synthetic Cannabinoid Receptor Agonists with Analytical Confirmation.
Topics: Adamantane; Administration, Intravenous; Anti-Anxiety Agents; Cannabinoid Receptor Agonists; Citalopram; Female; Fluoxetine; Hallucinations; Hallucinogens; Humans; Indazoles; Indoles; Lysergic Acid Diethylamide; Midazolam; Psychomotor Agitation; Quinolines; Seizures; Tachycardia; Time Factors; Young Adult | 2016 |
Validation of an LC-MS/MS method for the quantitative analysis of 1P-LSD and its tentative metabolite LSD in fortified urine and serum samples including stability tests for 1P-LSD under different storage conditions.
Topics: Adolescent; Blood Chemical Analysis; Calibration; Catalysis; Chromatography, Liquid; Humans; Hydrolysis; Limit of Detection; Lysergic Acid Diethylamide; Male; Midazolam; Phenmetrazine; Specimen Handling; Tandem Mass Spectrometry; Temperature; Urinalysis | 2019 |
An apathetic child with hallucinations.
Topics: Apathy; Child; Hallucinations; Hallucinogens; Humans; Lysergic Acid Diethylamide; Male; Midazolam | 2021 |